logo
Share SHARE
FONT-SIZE Plus   Neg

Genmab: Daratumumab Granted Fast Track Designation By FDA - Quick Facts

Genmab A/S (GNMSF.PK) announced that the US Food and Drug Administration has granted Fast Track designation for daratumumab. This designation covers patients with multiple myeloma who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD) or are double refractory to a PI and an IMiD.

In August 2012, Genmab granted Janssen Biotech, Inc. an exclusive worldwide license to develop and commercialize daratumumab.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The World Health Organization or WHO on Tuesday asked the tobacco industry to compensate for the massive environment issues caused by tobacco growing and usage. WHO, in its first report on tobacco's impact on the environment, said the extensive use of chemicals, energy and water, and pollution from manufacturing and distribution of tobacco products, cause massive harm to the environment. Shares of Ryanair Holdings Plc were losing around 2 percent in the early morning trading in London after the Irish no-frills airline Tuesday said it is cautiously guiding a profit increase in fiscal 2018 after reporting weak profit in fiscal 2017. The latest year profit was hurt by the absence of prior year's gain, while revenues increased with strong traffic growth. Hampton Farms has voluntarily recalled Ava's brand organic cashews for potential Listeria contamination. The Organic Cashews Roasted & Salted 8 oz. tubs were distributed in New Jersey, New York, Pennsylvania and Connecticut. As per the recall statement, fewer than 225 units of this product were offered for retail sale.
comments powered by Disqus
Follow RTT